Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 207

1.

Frequency of malignancy seen in probably benign lesions at contrast-enhanced breast MR imaging: findings from ACRIN 6667.

Weinstein SP, Hanna LG, Gatsonis C, Schnall MD, Rosen MA, Lehman CD.

Radiology. 2010 Jun;255(3):731-7. doi: 10.1148/radiol.10081712.

PMID:
20501712
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Use of BI-RADS 3-probably benign category in the American College of Radiology Imaging Network Digital Mammographic Imaging Screening Trial.

Baum JK, Hanna LG, Acharyya S, Mahoney MC, Conant EF, Bassett LW, Pisano ED.

Radiology. 2011 Jul;260(1):61-7. doi: 10.1148/radiol.11101285. Epub 2011 Apr 18.

PMID:
21502382
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Positive predictive value of BI-RADS MR imaging.

Mahoney MC, Gatsonis C, Hanna L, DeMartini WB, Lehman C.

Radiology. 2012 Jul;264(1):51-8. doi: 10.1148/radiol.12110619. Epub 2012 May 15.

PMID:
22589320
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Role of breast MR imaging for predicting malignancy of histologically borderline lesions diagnosed at core needle biopsy: prospective evaluation.

Pediconi F, Padula S, Dominelli V, Luciani M, Telesca M, Casali V, Kirchin MA, Passariello R, Catalano C.

Radiology. 2010 Dec;257(3):653-61. doi: 10.1148/radiol.10100732. Epub 2010 Sep 30.

PMID:
20884914
[PubMed - indexed for MEDLINE]
5.

Screening breast MR imaging: comparison of interpretation of baseline and annual follow-up studies.

Abramovici G, Mainiero MB.

Radiology. 2011 Apr;259(1):85-91. doi: 10.1148/radiol.10101009. Epub 2011 Feb 1.

PMID:
21285337
[PubMed - indexed for MEDLINE]
6.

Probably benign lesions at screening breast US in a population with elevated risk: prevalence and rate of malignancy in the ACRIN 6666 trial.

Barr RG, Zhang Z, Cormack JB, Mendelson EB, Berg WA.

Radiology. 2013 Dec;269(3):701-12. doi: 10.1148/radiol.13122829. Epub 2013 Oct 28.

PMID:
23962417
[PubMed - indexed for MEDLINE]
7.

Results of MR imaging screening for breast cancer in high-risk patients with lobular carcinoma in situ.

Friedlander LC, Roth SO, Gavenonis SC.

Radiology. 2011 Nov;261(2):421-7. doi: 10.1148/radiol.11103516. Epub 2011 Sep 7.

PMID:
21900618
[PubMed - indexed for MEDLINE]
8.

Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value?

Uematsu T, Yuen S, Kasami M, Uchida Y.

Breast Cancer Res Treat. 2007 Jul;103(3):269-81. Epub 2006 Oct 25.

PMID:
17063274
[PubMed - indexed for MEDLINE]
9.

Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions.

Pediconi F, Catalano C, Roselli A, Padula S, Altomari F, Moriconi E, Pronio AM, Kirchin MA, Passariello R.

Radiology. 2007 Jun;243(3):670-80. Epub 2007 Apr 19.

PMID:
17446524
[PubMed - indexed for MEDLINE]
10.

MR imaging in probably benign lesions (BI-RADS category 3) of the breast.

Gökalp G, Topal U.

Eur J Radiol. 2006 Mar;57(3):436-44. Epub 2005 Nov 28.

PMID:
16316732
[PubMed - indexed for MEDLINE]
11.

Role of magnetic resonance imaging in probably benign (BI-RADS category 3) microcalcifications of the breast.

Linda A, Zuiani C, Londero V, Di Gaetano E, Dal Col A, Girometti R, Bazzocchi M.

Radiol Med. 2014 Jun;119(6):393-9. doi: 10.1007/s11547-013-0361-0. Epub 2013 Dec 3.

PMID:
24297595
[PubMed - indexed for MEDLINE]
12.

Dynamic contrast-enhanced breast MR imaging in men: preliminary results.

Morakkabati-Spitz N, Schild HH, Leutner CC, von Falkenhausen M, Lutterbey G, Kuhl CK.

Radiology. 2006 Feb;238(2):438-45. Epub 2005 Dec 21.

PMID:
16371581
[PubMed - indexed for MEDLINE]
13.

Characteristics of probably benign breast MRI lesions.

Eby PR, DeMartini WB, Gutierrez RL, Saini MH, Peacock S, Lehman CD.

AJR Am J Roentgenol. 2009 Sep;193(3):861-7. doi: 10.2214/AJR.08.2096.

PMID:
19696303
[PubMed - indexed for MEDLINE]
14.

False-positive findings at contrast-enhanced breast MRI: a BI-RADS descriptor study.

Baltzer PA, Benndorf M, Dietzel M, Gajda M, Runnebaum IB, Kaiser WA.

AJR Am J Roentgenol. 2010 Jun;194(6):1658-63. doi: 10.2214/AJR.09.3486.

PMID:
20489110
[PubMed - indexed for MEDLINE]
15.

Risk of malignancy in palpable solid breast masses considered probably benign or low suspicion: implications for management.

Giess CS, Smeglin LZ, Meyer JE, Ritner JA, Birdwell RL.

J Ultrasound Med. 2012 Dec;31(12):1943-9.

PMID:
23197547
[PubMed - indexed for MEDLINE]
Free Article
16.

Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution.

Kuhl CK, Schild HH, Morakkabati N.

Radiology. 2005 Sep;236(3):789-800.

PMID:
16118161
[PubMed - indexed for MEDLINE]
17.

MR imaging-guided 9-gauge vacuum-assisted core-needle breast biopsy: initial experience.

Orel SG, Rosen M, Mies C, Schnall MD.

Radiology. 2006 Jan;238(1):54-61. Epub 2005 Nov 22.

PMID:
16304093
[PubMed - indexed for MEDLINE]
18.

Screening breast MR imaging in women with a history of lobular carcinoma in situ.

Sung JS, Malak SF, Bajaj P, Alis R, Dershaw DD, Morris EA.

Radiology. 2011 Nov;261(2):414-20. doi: 10.1148/radiol.11110091. Epub 2011 Sep 7.

PMID:
21900617
[PubMed - indexed for MEDLINE]
19.

Screening US in patients with mammographically dense breasts: initial experience with Connecticut Public Act 09-41.

Hooley RJ, Greenberg KL, Stackhouse RM, Geisel JL, Butler RS, Philpotts LE.

Radiology. 2012 Oct;265(1):59-69. Epub 2012 Jun 21.

PMID:
22723501
[PubMed - indexed for MEDLINE]
20.

BI-RADS lexicon for US and mammography: interobserver variability and positive predictive value.

Lazarus E, Mainiero MB, Schepps B, Koelliker SL, Livingston LS.

Radiology. 2006 May;239(2):385-91. Epub 2006 Mar 28.

PMID:
16569780
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk